Specific and nonspecific immunity in the prevention of spontaneous tumours
- 1 August 1999
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 20 (8) , 347-350
- https://doi.org/10.1016/s0167-5699(99)01450-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cytokine gene therapy: Hopes and pitfallsAnnals of Oncology, 1999
- The Leeuwenhoek Lecture, 1997: Marek's disease herpesvirus: oncogenesis and preventionPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1997
- Antitumor Efficacy of Adenocarcinoma Cells Engineered to Produce Interleukin 12 (IL-12) or Other Cytokines Compared With Exogenous IL-12JNCI Journal of the National Cancer Institute, 1997
- Human tumour antigens recognized by T cells: new perspectives for anti-cancer vaccines?Molecular Medicine Today, 1997
- Cytokines, tumour-cell death and immunogenicity: a question of choiceImmunology Today, 1997
- Immunotherapy I: Cyclosine gene transfer strategiesCancer and Metastasis Reviews, 1996
- The advent of the ‘unpatients’Nature Medicine, 1996
- Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.The Journal of Experimental Medicine, 1996
- Gene Transfer as Cancer TherapyPublished by Elsevier ,1995
- Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells.The Journal of Experimental Medicine, 1992